Lidocaine and surgical modification reduces mortality in a rat model of cardiac failure induced by coronary artery ligation

J Pharmacol Toxicol Methods. 2000 May-Jun;43(3):199-203. doi: 10.1016/s1056-8719(00)00103-9.

Abstract

Coronary artery ligation in the rat provides a useful experimental model of cardiac failure; however, this procedure carries with it a high mortality rate (50%). In this study, we used lidocaine (10 mg/kg, i.m.) before coronary artery ligation and 2 h after surgery to minimise the incidence of ventricular fibrillation (VF) that leads to sudden death in this model. We found that coronary artery ligation, using lidocaine in conjunction with a modified surgical procedure, had a mortality rate of 15%, much lower than reported in previous studies using this model. These modifications allow for the production of larger infarcts with 29% of animals having an infarct size > 50% of the epicardial surface. Infarct size in our myocardial infarction (MI) group varied between 5% and 75% of the left ventricular (LV) surface area resulting in a mean infarct size of 41.3 +/- 1.3% for the epicardial surface and 40.0 +/- 1.3% for the endocardial surface.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / therapeutic use*
  • Body Weight
  • Coronary Vessels / physiology*
  • Heart Failure / drug therapy
  • Heart Failure / surgery
  • Heart Failure / therapy*
  • Lidocaine / therapeutic use*
  • Ligation
  • Male
  • Myocardial Infarction / pathology
  • Myocardium / pathology
  • Organ Size
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anti-Arrhythmia Agents
  • Lidocaine